Correction to: Cancer Immunology, Immunotherapy https://doi.org/10.1007/s00262-020-02824-0

The original version of this article unfortunately contained a mistake. NCT number is incorrect. The correct number is NCT03275402.

In section “Case presentation”, first sentence of the second paragraph should read as

The patient underwent treatment according to Memorial Sloan Kettering Cancer Center salvage regimen consisting of craniospinal radiation therapy, chemotherapy and intraventricular 131I-omburtamab on a phase 2 IRB-approved protocol (NCT03275402) [1].

Ethics approval section should read as

Patient (proxy) consented to be treated on IRB approved protocol registered to clinicaltrials.gov NCT03275402.